BIODELIVERY SCIENCES INTERNATIONAL INC - FORM 10-Q - EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - August 7, 2014

Attached files

file filename
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - BIODELIVERY SCIENCES INTERNATIONAL INCd731813dex322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - BIODELIVERY SCIENCES INTERNATIONAL INCd731813dex311.htm
EX-10.1 - FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT - BIODELIVERY SCIENCES INTERNATIONAL INCd731813dex101.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - BIODELIVERY SCIENCES INTERNATIONAL INCd731813dex312.htm
EXCEL - IDEA: XBRL DOCUMENT - BIODELIVERY SCIENCES INTERNATIONAL INCFinancial_Report.xls
10-Q - FORM 10-Q - BIODELIVERY SCIENCES INTERNATIONAL INCd731813d10q.htm

Exhibit 32.1

BIODELIVERY SCIENCES INTERNATIONAL, INC.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BioDelivery Sciences International, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark A. Sirgo, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Mark A. Sirgo

Mark A. Sirgo

President and Chief Executive Officer

August 7, 2014

BIODELIVERY SCIENCES INTERNATIONAL INC Reports